RAIN
Income statement / Annual
Last year (2022), Rain Therapeutics Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2022, Rain Therapeutics Inc.'s net income was -$75.72 M.
See Rain Therapeutics Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$61.40 M
|
$40.77 M
|
$15.37 M
|
$7.29 M
|
| General & Administrative
Expenses |
$15.74 M
|
$10.74 M
|
$3.59 M
|
$3.54 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$15.74 M
|
$10.74 M
|
$3.59 M
|
$3.54 M
|
| Other Expenses |
$0.00 |
$1,000.00 |
-$2.02 M |
-$251,000.00 |
| Operating Expenses |
$77.14 M |
$51.51 M |
$18.96 M |
$10.83 M |
| Cost And Expenses |
$77.14 M |
$51.51 M |
$18.96 M |
$10.83 M |
| Interest Income |
$1.42 M |
$119,000.00 |
$32,000.00 |
$209,000.00 |
| Interest Expense |
$0.00 |
$0.00 |
$135,000.00 |
$32,000.00 |
| Depreciation &
Amortization |
$80,000.00
|
$120,000.00
|
-$1.94 M
|
-$14,000.00
|
| EBITDA |
-$77.06 M
|
-$51.51 M
|
-$18.91 M
|
-$10.84 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$1.42 M
|
$120,000.00
|
-$2.13 M
|
-$74,000.00
|
| Income Before Tax |
-$75.72 M |
-$51.39 M |
-$21.08 M |
-$10.90 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$3,000.00 |
$2,000.00 |
-$1.89 M |
-$219,000.00 |
| Net Income |
-$75.72 M |
-$51.39 M |
-$19.20 M |
-$10.68 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
| EPS |
-2.71 |
-2.65 |
-1.8 |
-1 |
| EPS Diluted |
-2.71 |
-2.65 |
-1.8 |
-1 |
| Weighted Average Shares
Out |
$27.99 M
|
$19.41 M
|
$10.66 M
|
$10.66 M
|
| Weighted Average Shares
Out Diluted |
$27.99 M
|
$19.41 M
|
$10.66 M
|
$10.66 M
|
| Link |
|
|
|
|
